Diphenhydramine vs Ipilimumab

Diphenhydramine vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Diphenhydramine and Ipilimumab.

Mechanism of Action

Diphenhydramine: First-generation H1 antihistamine with anticholinergic properties.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Diphenhydramine — 2-8 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Diphenhydramine — C17H21NO.

Molecular Weight: Diphenhydramine — 255.3550 g/mol.

Type: Diphenhydramine — Small molecule; Ipilimumab — Antibody.